222 related articles for article (PubMed ID: 32456484)
1. Advances in the study of drug metabolism - symposium report of the 12th Meeting of the International Society for the Study of Xenobiotics (ISSX).
Russell LE; Schleiff MA; Gonzalez E; Bart AG; Broccatelli F; Hartman JH; Humphreys WG; Lauschke VM; Martin I; Nwabufo C; Prasad B; Scott EE; Segall M; Takahashi R; Taub ME; Sodhi JK
Drug Metab Rev; 2020 Aug; 52(3):395-407. PubMed ID: 32456484
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics in drug disposition & drug therapy: symposium report of the 24
Maldonato BJ; Vergara AG; Yadav J; Glass SM; Paragas EM; Li D; Lazarus P; McClay JL; Ning B; Daly AK; Russell LE
Drug Metab Rev; 2022 Aug; 54(3):318-330. PubMed ID: 35876105
[TBL] [Abstract][Full Text] [Related]
3. Computational methods and tools to predict cytochrome P450 metabolism for drug discovery.
Tyzack JD; Kirchmair J
Chem Biol Drug Des; 2019 Apr; 93(4):377-386. PubMed ID: 30471192
[TBL] [Abstract][Full Text] [Related]
4. Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.
Kirchmair J; Williamson MJ; Tyzack JD; Tan L; Bond PJ; Bender A; Glen RC
J Chem Inf Model; 2012 Mar; 52(3):617-48. PubMed ID: 22339582
[TBL] [Abstract][Full Text] [Related]
5. DMW/ISSX 2000 Meeting. The Drug Metabolism Workshop/International Society for the Study of Xenobiotics. St. Andrews, Scotland, June 11-16, 2000. Abstracts.
Drug Metab Rev; 2000; 32 Suppl 1():1-136. PubMed ID: 10909680
[No Abstract] [Full Text] [Related]
6. International Society for the Study of Xenobiotics (ISSX) New Investigator Group Committee 2019-2020 concluding remarks.
Schleiff MA; Sodhi JK
Drug Metab Rev; 2021 May; 53(2):279-284. PubMed ID: 33836131
[TBL] [Abstract][Full Text] [Related]
7. Future of Biotransformation Science in the Pharmaceutical Industry.
Kramlinger VM; Dalvie D; Heck CJS; Kalgutkar AS; O'Neill J; Su D; Teitelbaum AM; Totah RA
Drug Metab Dispos; 2022 Mar; 50(3):258-267. PubMed ID: 34921097
[TBL] [Abstract][Full Text] [Related]
8. Abstracts from the 14th North American ISSX (International Society for the Study of Xenobiotics)Meeting, October 22-26, 2006, Rio Grande, Puerto Rico, USA.
Drug Metab Rev; 2006; 38 Suppl 2():1-258. PubMed ID: 17378085
[No Abstract] [Full Text] [Related]
9. ISSX North American symposium on risk assessment and the biological fate of xenobiotics. International Society for the Study of Xenobiotics. 17-22 November 1985, Key Biscayne, Florida, USA. Proceedings.
Xenobiotica; 1987 Mar; 17(3):253-422. PubMed ID: 3577203
[No Abstract] [Full Text] [Related]
10. Abstracts of the 12th North American ISSX Meeting. October 12-16, 2003. Providence, Rhode Island, USA.
Drug Metab Rev; 2003; 35 Suppl 2():1-255. PubMed ID: 14601621
[No Abstract] [Full Text] [Related]
11. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
Dobrić I
Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
[TBL] [Abstract][Full Text] [Related]
12. In silico modeling of p450 substrates, inhibitors, activators, and inducers.
DeLisle RK; Otten J; Rhodes S
Comb Chem High Throughput Screen; 2011 Jun; 14(5):396-416. PubMed ID: 21470185
[TBL] [Abstract][Full Text] [Related]
13. Abstracts of the 18th North American Regional ISSX (International Society for the Study of Xenobiotics) Meeting. October 14-18, 2012. Dallas, Texas, USA.
Drug Metab Rev; 2012; 44 Suppl 1():6-158. PubMed ID: 23193565
[No Abstract] [Full Text] [Related]
14. Abstracts of the 17th North American Regional ISSX International Society for the Study of Xenobiotics) Meeting. October 16–20, 2011. Atlanta, Georgia, USA.
Drug Metab Rev; 2011 Nov; 43 Suppl 2():1-230. PubMed ID: 22148146
[No Abstract] [Full Text] [Related]
15. Abstracts of the 16th North American Regional ISSX (International Society for the Study of Xenobiotics) Meeting. October 18-22, 2009. Baltimore, Maryland, USA.
Drug Metab Rev; 2009 Oct; 41 Suppl 3():7-186. PubMed ID: 19758100
[No Abstract] [Full Text] [Related]
16. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
[TBL] [Abstract][Full Text] [Related]
17. Abstracts of the 9th International Society for the Study of Xenobiotics (ISSX) Meeting. September 4-8, 2010. Istanbul, Turkey.
Drug Metab Rev; 2010 Aug; 42 Suppl 1():S1-323. PubMed ID: 20842800
[No Abstract] [Full Text] [Related]
18. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
Rushmore TH; Kong AN
Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
[TBL] [Abstract][Full Text] [Related]
19. Abstracts of 4th Asia Pacific Regional Meeting of the International Society for the Study of Xenobiotics (ISSX). T'ainan, Taiwan. April 22-25, 2011.
Drug Metab Rev; 2011 May; 43 Suppl 1():1-96. PubMed ID: 21528498
[No Abstract] [Full Text] [Related]
20. Advances in drug metabolism and pharmacogenetics research in Australia.
Mackenzie PI; Somogyi AA; Miners JO
Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
